FDA Approved: RADICAVA — Supplemental Application (Shionogi Inc.)

View source ↗

Summary

The FDA approved a supplemental application for RADICAVA (edaravone) submitted by Shionogi Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Radicava (edaravone)

Snippet

SUPPL AP for RADICAVA (EDARAVONE)